A groundbreaking clinical trial at the University of Oxford explores the potential of using parasitic tick saliva to treat type 1 diabetes.
The study aims to eliminate the need for immunosuppressant drugs in patients receiving beta cell transplants, a key challenge in treating the condition.
Current therapies require immunosuppressant drugs to prevent the immune system from attacking the transplanted cells.
Researchers believe that parasitic ticks, which have evolved to evade the immune system, could offer a solution. By harnessing the ticks’ ability to avoid immune detection, the team hopes to protect transplanted beta cells without the need for immunosuppressants.
Source: Oman News Agency
